港股異動丨賓仕國際(01705.HK)暴漲68.67% 奈雪的茶已交招股書
格隆匯2月16日丨中國內地連鎖茶飲品牌“奈雪的茶”在除夕低調提交招股書,市場預計3月在港股上市,擁有天仁茗茶香港特許經營權的賓仕國際(01705.HK)亦借勢大炒“影子股”效應,現暴漲68.67%,報0.7港元,盤中高見0.85港元,總市值2.8億港元。據悉,奈雪的茶計劃集資4億至5億美元(31億至38.8億港元),摩根大通、招銀國際及華泰國際擔任保薦人。根據初步招股文件顯示,集團去年首3季虧損由上年同期387.1萬元,擴大至2751萬元人民幣。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.